Revance Therapeutics

Revance Therapeutics is a biopharmaceutical company focused on developing and commercializing products for dermatology and aesthetics. Its lead product, RT001, is a topical botulinum toxin type A for cosmetic use, hyperhidrosis treatment, and other dermatological indications.

Mark Foley

CEO and Board Member

1 past transactions

HintMD

Acquisition in 2020
HintMD is a cloud-based patient engagement and payments platform tailored for medical aesthetic practitioners, founded in 2014 and headquartered in Pleasanton, California. The company collaborates with board-certified physicians to identify gaps in patient care, providing personalized treatment plan subscription solutions that enhance patient engagement and compliance while improving clinical outcomes. By offering patients the ability to manage their treatment plans through convenient monthly payments, HintMD aims to facilitate better beauty outcomes for consumers and support the financial performance of over 30,000 physician-owned practices in the medical aesthetic industry. The platform contributes to significant improvements in compliance, patient satisfaction, and overall practice revenue and profitability.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.